Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Neoplasms 3Constipation 2Urinary Bladder Neoplasms 1Pain 1Opioid-Induced Constipation 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Surveys and Questionnaires 15Acupuncture Therapy 15Fentanyl 14Morphine 13Acetaminophen 13Analgesia 12Lidocaine 11Ketamine 11Bupivacaine 11Methadone 10Therapeutics 9Ropivacaine 9Psychiatric Rehabilitation 9Oxycodone 9Hydromorphone 7Saline Solution 6Radiotherapy 6Music Therapy 6Early Intervention, Educational 6Zoledronic Acid 5Yoga 5Water 5Methods 5Control Groups 5Transcutaneous Electric Nerve Stimulation 4Therapeutic Touch 4Physical Therapy Modalities 4Massage 4Ketorolac 4Exercise 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pain × naloxegol × Clear all
NCT02839889 2019-03-05

Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)

Hospice of Henderson County, Inc.

Phase 4 Terminated
12 enrolled 33 charts
Other

Constipation, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡